Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Features of optical coherence tomography are predictive of visual outcomes after intravitreal bevacizumab injection for diabetic macular edema Roh MI; Kim JH; Kwon OWOphthalmologica 2010[]; 224 (6): 374-80PURPOSE: To identify optical coherence tomography (OCT) patterns of diabetic macular edema (DME) predictive of visual outcomes after intravitreal bevacizumab (IVB; Avastin(R)) injection. METHODS: We retrospectively examined 56 consecutive eyes that were given IVB injections for DME alongside the preoperative macular OCT data. Using this information, we categorized the eyes into 2 groups: group 1 showing diffuse patterns; group 2 demonstrating cystoid macular edema (CME). RESULT: The mean follow-up period was 11.66 +/- 3.98 months. Group 1 eyes gained 0.04 +/- 9.27 ETDRS letters (p = 0.984), while group 2 eyes gained 5.79 +/- 9.98 ETDRS letters (p = 0.005). Mean macular thickness decreased by 72.79 +/- 145.74 mum in group 1 (p = 0.014) and by 223.71 +/- 224.52 mum in group 2 (p< 0.001). CONCLUSION: Patients showing CME upon OCT achieved greater improvements in visual acuity and macular thickness after IVB injection than patients with diffuse macular edema. The type of macular edema shown by OCT may provide an objective guideline in predicting the response of DME to IVB injection.|*Tomography, Optical Coherence[MESH]|Adult[MESH]|Aged[MESH]|Antibodies, Monoclonal, Humanized[MESH]|Antibodies, Monoclonal/*administration & dosage[MESH]|Bevacizumab[MESH]|Diabetic Retinopathy/diagnosis/*drug therapy/physiopathology[MESH]|Female[MESH]|Follow-Up Studies[MESH]|Humans[MESH]|Injections, Intraocular[MESH]|Macular Edema/diagnosis/*drug therapy/physiopathology[MESH]|Male[MESH]|Middle Aged[MESH]|Predictive Value of Tests[MESH]|Retrospective Studies[MESH]|Treatment Outcome[MESH]|Vascular Endothelial Growth Factor A/*antagonists & inhibitors[MESH]|Visual Acuity/drug effects[MESH]|Vitreous Body[MESH] |
